Gamida Cell Ltd. GMDA
Set alert
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 4.34M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -0.06
- Beta
- 1.03
- Short ratio
- 3.51
- Inst. own
- 26.49%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 20, 2024
- 50-d avg
- 0.242678
- 200-d avg
- 0.627926
- 1y target
- 4.00
News
1 year ago businesswire.com
Gamida Cell Presents Positive Initial Results on Treating Severe Aplastic Anemia (SAA) with Omidubicel
LONDON--(BUSINESS WIRE)--Ayrmid Ltd. (“Ayrmid” or the “Company”), the parent company of Gamida Cell Inc., a cell therapy pioneer working to turn cells into powerful therapeutics, announced positive…
2 years ago globenewswire.com
On Path to First-in-Human Study, NurExone Engages Prominent Expert in Biological Drug Development
TORONTO and HAIFA, Israel, June 21, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company,…
2 years ago businesswire.com
Gamida Cell Announces New Leadership Under Ownership of Highbridge Capital Management
BOSTON--(BUSINESS WIRE)--Gamida Cell (the “Company”), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced new executive leadership following a successful…
-
2 years ago benzinga.com
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly…
-
2 years ago benzinga.com
Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Shares of RH (NYSE: RH) rose sharply in today’s pre-market trading following the release of quarterly results.
2 years ago investorplace.com
Why Is Gamida Cell (GMDA) Stock Down 82% Today?
Gamida Cell (NASDAQ: GMDA ) stock is falling hard on Wednesday after the clinical-stage biopharmaceutical company announced major changes to its business in its Q4 earnings report. This big news here…
2 years ago seekingalpha.com
Gamida Cell Ltd. (GMDA) Q4 2023 Earnings Call Transcript
Gamida Cell Ltd. (GMDA) Q4 2023 Earnings Call Transcript
2 years ago globenewswire.com
Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update
Company announces commencement of restructuring process supported by Highbridge Capital Management Continued progress of launch of Omisirge ® (omidubicel-onlv), with the delivery of six units in…
2 years ago globenewswire.com
Gamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital Management
Company expected to receive significant new capital from Highbridge to bolster the commercialization of allogeneic stem cell transplant Omisirge ® (omidubicel-onlv)
-
2 years ago benzinga.com
Earnings Scheduled For March 27, 2024
Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million.
2 years ago globenewswire.com
Gamida Cell to Report Fourth Quarter and Full-Year 2023 Financial Results
BOSTON, March 22, 2024 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that the company will release its…
2 years ago globenewswire.com
Gamida Cell Data Presented at the 2024 Tandem Meetings of ASTCT® and CIBMTR®
Expanded access program (EAP) data for omidubicel are consistent with Phase 3 trial results on rates of hematopoietic recovery and infections following stem cell transplant with Omisirge ®…
2 years ago globenewswire.com
Gamida Cell Actively Pursuing Strategic Alternatives
BOSTON, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced it is actively pursuing strategic…
2 years ago globenewswire.com
Gamida Cell to Present at the 2024 Tandem Meetings of ASTCT® and CIBMTR®
BOSTON, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced it will present new data on its FDA…
2 years ago globenewswire.com
Gamida Cell to Host Virtual Thought Leader Fireside Chat on December 4, 2023
BOSTON, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, is hosting a virtual fireside chat with thought…
2 years ago globenewswire.com
Gamida Cell to Present Corporate Highlights at the Piper Sandler 35th Annual Healthcare Conference
BOSTON, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that its management team will…
-
2 years ago benzinga.com
Small-Caps Grossly Underperform Broader Market Amid This Red Flag: 5 Stocks On The Scanner
Small-cap stocks have not taken off significantly this year despite the broader market rebound, primarily due to their increasing debt burden, a report says.
2 years ago seekingalpha.com
Gamida Cell Ltd. (GMDA) Q3 2023 Earnings Call Transcript
Gamida Cell Ltd. (NASDAQ:GMDA ) Q3 2023 Earnings Conference Call November 14, 2023 8:30 AM ET Company Participants Mike Kuczkowski - Corporate Communications Abbey Jenkins - President & Chief…
-
2 years ago benzinga.com
Earnings Scheduled For November 14, 2023
Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue of $18.00 million.
2 years ago globenewswire.com
Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company Update
Company continues to advance launch, reports initial revenue from Omisirge ® (omidubicel-onlv)
2 years ago globenewswire.com
Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual Meeting
Data further characterize the mechanism for Gamida Cell's proprietary nicotinamide (NAM) technology's expansion and enhancement of cells Data further characterize the mechanism for Gamida Cell's…
3 years ago globenewswire.com
Gamida Cell to Report Third Quarter 2023 Financial Results
BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that the company will release its…
3 years ago businesswire.com
Gamida Cell Reports Preliminary Data from Phase 1 Study of Natural Killer (NK) Cell Therapy Candidate GDA-201
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced new early data in 10 patients with CD20 positive…
3 years ago businesswire.com
Gamida Cell Issues Update on Israel Operations
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today issued an update on its operations in Israel. “We remain…
3 years ago marketwatch.com
These Israeli pharmaceutical stocks are down in the wake of Hamas attack
Shares of Israeli pharmaceutical companies took a hit in premarket trades Monday after Hamas' attack on Israel.
-
3 years ago benzinga.com
Earnings Scheduled For August 14, 2023
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.
-
3 years ago benzinga.com
Earnings Scheduled For May 15, 2023
Companies Reporting Before The Bell • Caledonia Mining (AMEX:CMCL) is expected to report earnings for its first quarter. • Sohu.com (NASDAQ:SOHU) is projected to report earnings for its first quarter.
-
3 years ago benzinga.com
Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
On Monday, 89 stocks made new 52-week lows.
-
3 years ago benzinga.com
Earnings Scheduled For March 27, 2023
Companies Reporting Before The Bell • Viomi Technology Co (NASDAQ:VIOT) is likely to report earnings for its fourth quarter. • Vislink Technologies (NASDAQ:VISL) is projected to report earnings for…
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
Monday saw 196 companies set new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
On Friday, 127 companies set new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
During Thursday's trading, 138 companies set new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
Wednesday saw 219 companies set new 52-week lows.
-
3 years ago benzinga.com
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 361 companies set new 52-week lows.
-
4 years ago benzinga.com
Earnings Scheduled For August 15, 2022
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.
-
4 years ago benzinga.com
Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday
Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 120 companies achieved new lows for the year.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
On Monday, 100 companies reached new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 61 companies made new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 588 stocks hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
During Monday's trading, 1214 companies set new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
On Friday, 422 stocks made new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 215 companies set new 52-week lows.
-
4 years ago benzinga.com
Earnings Scheduled For May 10, 2022
Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.
-
4 years ago benzinga.com
Earnings Scheduled For March 15, 2022
Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likely to report quarterly loss at $0.31 per share on revenue of $8.98 million.
-
4 years ago benzinga.com
52 Biggest Movers From Yesterday
Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares surged 65.7% to close at $25.92 on Wednesday after the company announced it will be acquired by UCB for approximately $1.9 billion.
-
4 years ago benzinga.com
35 Stocks Moving In Wednesday's Mid-Day Session
Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares jumped 67.1% to $26.15 after the company announced it will be acquired by UCB for approximately $1.9 billion.
-
4 years ago benzinga.com
Earnings Scheduled For November 15, 2021
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its third quarter.